Thrombosis and Haemostasis, Table of Contents Thromb Haemost 2003; 90(01): 159-160DOI: 10.1055/s-0037-1613615 Letters to the Editor Schattauer GmbH Oral anticoagulant therapy: should doctors change the way they give patients explanations ? Doris Barcellona , Lara Fenu , Francesco Marongiu Recommend Article Abstract Buy Article Full Text References References 1 Laporte S, Quenet S, Buchmuller-Cordier A. et al. Compliance and stability of INR of two oral anticoagulants with different half-lives: a randomised trial. Thromb Haemost 2003; 89: 458-67. 2 Pattaccini C, Tagliaferri A, Manotti C. Awarness of teratogenic effect of oral anticoagulants in fertile women. Thromb Haemost 2002; 88: 172 3 Barcellona D, Contu P, Marongiu F. Patient education and oral anticoagulant therapy. Haematologica 2002; 87: 1081-86. 4 Barcellona D, Contu P, Sorano GG. et al. The management of oral anticoagulant therapy: the patient’s point of view. Thromb Haemost 2000; 83: 49-53. 5 Barcellona D, Vannini ML, Fenu L. et al. Warfarin or acenocoumarol: which is better in the management of oral anticoagulants ?. Thromb Haemost 1998; 80: 899-902.
